Cytosorbents Corporation

NASDAQ: CTSO · Real-Time Price · USD
1.15
0.01 (0.88%)
At close: Aug 15, 2025, 3:59 PM
1.14
-0.42%
After-hours: Aug 15, 2025, 06:51 PM EDT

Cytosorbents Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
9.62M 8.73M 6.52M 8.61M 8.84M 8.99M 7.35M 7.75M 8.07M 7.91M 7.64M 6.46M 7.33M 7.92M 9.7M 8.9M 11.37M 10.14M
Cost of Revenue
2.8M 2.52M 247.87K 4.11M 3.39M 3.22M 3.36M 3.2M 3.4M 3.99M 3.63M 4.49M 3.55M 2.28M 3.12M 2.46M 2.71M 2.75M
Gross Profit
6.81M 6.21M 6.77M 4.5M 6.5M 6.87M 5M 4.55M 4.67M 3.92M 4.01M 1.97M 3.78M 5.65M 6.58M 6.44M 8.65M 7.85M
Operating Income
-3.62M -3.89M -4.04M -4.4M -3.42M -4.66M -9.64M -7.35M -6.56M -7.89M -6.36M -9.02M -8.36M -7.79M -9.56M -5.41M -4.92M -2.85M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a 8.82K n/a 53.75K 46.84K 23.97K 8.03K 12.29K 12.77K 13.07K n/a
Pretax Income
1.95M -1.48M -9.57M -2.33M -4.14M -6.09M -6.65M -9.19M -6.15M -7.33M -1.86M -12.2M -10.88M -8.97M -10.04M -6.41M -4.68M -4.17M
Net Income
1.95M -1.48M -7.88M -2.33M -4.14M -6.36M -5.83M -9.19M -6.15M -7.33M -766K -12.15M -10.88M -8.97M -9.31M -6.41M -4.68M -4.17M
Selling & General & Admin
9.17M 8.43M 9.83M 7.76M 8.4M 9.28M 9.24M 9.21M 8.91M 9.13M 8.71M 9.34M 9.12M 9.96M 11.08M 8.44M 10.54M 8.42M
Research & Development
1.26M 1.66M 1.3M 1.85M 1.52M 2.25M 4.1M 3.75M 3.67M 4.21M 3.4M 3.29M 4.18M 4.24M 6.14M 4.26M 3.7M 2.28M
Other Expenses
n/a n/a 1.58M 226.00 -382 -1.09K 1.31M -1.06M -1.35M -1.54M -1.75M -1.65M -1.17M -767K -1.08M -859K -659K -455K
Operating Expenses
10.43M 10.1M 12.71M 9.61M 9.92M 11.53M 14.64M 11.9M 11.39M 11.81M 10.37M 10.99M 12.14M 13.44M 16.14M 12.04M 13.58M 10.24M
Interest Expense
616K 605.13K 624.19K 588.15K 180.1K 6.65K 52.23K 33.67K 8.82K 63.17K 53.75K 46.84K n/a n/a n/a n/a n/a 10.12K
Selling & Marketing Expenses
n/a n/a 7.82M 7M n/a 35.16K -1.31M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
13.23M 12.61M 13.2M 13.01M 13.31M 13.65M 16.69M 15.1M 14.63M 15.8M 14M 15.48M 15.69M 15.72M 19.26M 14.31M 16.29M 13M
Income Tax Expense
n/a n/a -1.69M n/a -4 -3 -814K n/a n/a n/a -1.09M -46.84K n/a -8.03K -736K -12.77K -13.07K n/a
Shares Outstanding (Basic)
62.61M 60.73M 54.72M 54.72M 54.31M 54.26M 44.66M 44.37M 44.02M 43.68M 43.48M 43.58M 43.56M 42.7M 43.36M 42.71M 42.52M 41.68M
Shares Outstanding (Diluted)
67.17M 60.73M 54.72M 54.45M 54.31M 54.26M 44.66M 44.37M 44.02M 43.68M 43.48M 43.61M 43.56M 43.49M 43.48M 43.4M 43.32M 43.24M
EPS (Basic)
0.03 -0.02 -0.14 -0.04 -0.08 -0.11 -0.13 -0.21 -0.14 -0.17 -0.02 -0.28 -0.25 -0.21 -0.22 -0.15 -0.11 -0.1
EPS (Diluted)
0.03 -0.02 -0.14 -0.04 -0.08 -0.11 -0.13 -0.21 -0.14 -0.17 -0.02 -0.28 -0.25 -0.21 -0.21 -0.15 -0.11 -0.1
EBITDA
-3.62M -468K -11.09M -1.32M -2.97M -5.64M -6.1M -8.7M -6.1M -7.58M -6.08M -8.74M -8.06M -7.51M -9M -5.17M -4.8M -4M
EBIT
2.56M -873K -11.52M -1.75M -3.42M -6.08M -6.9M -9.16M -6.54M -7.89M -6.36M -9.02M -8.23M -7.79M -9.22M -5.41M -4.92M -4.16M
Depreciation & Amortization
440.25K 404.75K 431.94K 428.77K 446.51K 443.21K 792.67K 462.65K 457.4K 314.07K 278.65K 277.6K 293.29K 282.09K 214.4K 237.1K 123.75K 156.32K